Key result
Higher PM2.5 exposure linked to ~151 additional major cardiovascular events per 100,000 person-years per 1-µg/m³.
Why the study?
The extent to which blood pressure and arterial stiffness mediate the association between long-term PM2.5 exposure and cardiovascular risk, and whether individuals with metabolic impairment are more susceptible, remain unclear.
Does blood pressure and arterial stiffness (cfPWV) mediate the association between long-term PM2.5 exposure and incident MACE in middle-aged and older men free of baseline CHD and stroke?
Cohort (n=2,119)
Does blood pressure and arterial stiffness (cfPWV) mediate the association between long-term PM2.5 exposure and incident MACE in middle-aged and older men free of baseline CHD and stroke?
Large-artery stiffness (cfPWV) mediates 32% of the major adverse cardiovascular event burden associated with chronic PM2.5 exposure in middle-aged and older men, an effect that is amplified in those with impaired glucose or elevated LDL-cholesterol.
Answers are grounded in this paper and cite their sources.
No immediate clinical changes for older men with PM2.5 exposure; leaves open confirmation of arterial stiffness mediation in prospective studies.
Aims The extent to which blood pressure (BP) and arterial stiffness mediate the association between long-term PM2.5 exposure and cardiovascular risk, and whether individuals with metabolic impairment are more susceptible, remain unclear. Methods Within the “Risk of Cardiovascular diseases and abdominal aortic Aneurysms in Varese” (RoCAV) cohort, we retained 2119 men aged 50-75 and free of coronary heart disease (CHD) and stroke at baseline; carotid-femoral Pulse Wave Velocity (cfPWV) was measured in a subset of 1015 using an automated oscillometer. Exposure was the 12-month mean PM2.5 concentration before baseline (EXPANSE models); outcome was incident major acute CHD or stroke (MACE), fatal or non-fatal. We estimated the mediating contribution of BP and cfPWV through Marginal Structural Models and Aalen survival models, with individual- and area-level confounders. Results In a median follow-up of 7.6 years, 178 MACE events occurred (rate=1155 per 100,000 person-years), and 76 (1086/100,000 p-y) in the cfPWV subset. Systolic BP, mean BP, brachial pulse pressure and cfPWV were highest in the most exposed. Each 1-µg/m3 increase in PM2.5 was associated with 151 (95%CI:21-282) additional MACE events per 100,000 p-y, of which 48 (95%CI:17-79) were mediated by cfPWV (mediated proportion: 32%). Systolic BP and brachial pulse pressure each mediated about 16% of the PM2.5-associated risk. The cfPWV-mediated effect was enhanced in men with impaired glucose (96;95%CI:38-155) and elevated LDL-cholesterol (88;95%CI:28-147). Conclusions Large-artery stiffness substantially contributes to the MACE burden associated with chronic PM2.5 exposure, especially in men with metabolic impairment. Monitoring cfPWV may help incorporate environmental risk into cardiovascular prevention.
No takes yet. Share an insight, caveat, or question.
Veronesi et al. (2026) conducted a cohort in Cardiovascular disease risk (coronary heart disease or stroke) (n=2,119). Long-term PM2.5 exposure (12-month mean concentration before baseline) mediated by blood pressure and carotid-femoral pulse wave velocity (cfPWV) vs. Lower PM2.5 exposure (continuous per 1-µg/m3 increase) was evaluated on Incident major acute coronary heart disease or stroke (MACE), fatal or non-fatal (151 additional MACE events per 100,000 person-years per 1-µg/m3 PM2.5 increase (48 per 100,000 person-years [32%] mediated by cfPWV), 95% CI 21-282). Each 1-µg/m3 increase in PM2.5 exposure was associated with 151 additional major cardiovascular events per 100,000 person-years, with 32% mediated by arterial stiffness (cfPWV).
Synapse has enriched 10 related papers. Consider them for comparative context: